您的位置: 首页 > 农业专利 > 详情页

DERIVES INEDITS D'OXYNTOMODULINE ET COMPOSITION PHARMACEUTIQUE DESTINEE AU TRAITEMENT DE L'OBESITE EN CONTENANT
专利权人:
LTD.;HANMI SCIENCE CO.
发明人:
JANG, MYUNG HYUN,JUNG, SUNG YOUB,KWON, SE CHANG,PARK, YOUNG JIN,PARK, YOUNG KYUNG,SHEN, LING AI
申请号:
CA3064214
公开号:
CA3064214A1
申请日:
2012.06.07
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
The present invention relates to a novel peptide showing more excellentactivities on aglucagon like peptide-1 receptor and a glucagon receptor than nativeoxyntomodulin, and acomposition for the prevention or treatment of obesity comprising the peptideas an activeingredient. Unlike native oxyntomodulin, the novel peptide of the presentinvention reduces foodintake, suppresses gastric emptying, and facilitates lipolysis with reducedside-effects, and alsoshows excellent receptor-activating effects. Thus, it can be widely used inthe treatment of obesitywith safety and efficacy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充